跳到主要内容
Nelum
希腊的法律

Ministerial Joint Decree No. 117800 as regards maximum residue levels for ethofumesate, lambda−cyhalothrin, methomyl, pymetrozine and thiabendazole in and on certain products of plant origin, in compliance with Commission Directive 2005/74/EC

颁布于 2006-04-26 · 文本截至 2026-10-01

以研究形式发布的公开法律与官方指引,不构成法律、税务或金融建议。

研究内容本身以英文撰写。标题和标签已翻译,调查结果和引文未翻译。

关于这部法律

原标题
Κοινή Υπουργική Απόφαση υπ’αριθ. 117800. Ανώτατα Όρια Υπολειμμάτων (MRLs) των φυτοφαρμάκων ethofumesate, lambda−cyhalothrin, methomyl, pymetrozine και thiabendazole, επί και εντός τροφίμων φυτικής προέλευσης σε εναρμόνιση προς την οδηγία 2005/74/ΕΚ της Επιτροπής.
语言
Greek
类型
条例
组织
European Union
国家
希腊
主题
Food and nutrition
关键词
food safety and quality, MRL-maximum residue limit, residues, pesticides

在哪里阅读

    该法律没有记录来源链接。

文本

所收录的法律原文,按条款排列。每个条款都有自己的链接。

  1. 8183 E<l>HMEPII THI KYBEPNHIEnI THI EAAHNIKHI ~HMOKPATIAI TEYXOI .dEYTEPO nEPIEXOMENA AnO<l>AIEII AVWTOTO bpLO YnoA£LµµaTWV (MRLs) TWV cpurncpap­ µaKWV ethofumesate, lambda-cyhalothrin, methomyl, pymetrozine KOL thiabendazole, £TTL KOL £VT6c; Tpocp(µwv <pUTLKTJC: npoi::t\£uoric; 0£ £vapµovLOTJ npoc; TrJV ocir,v[a 2005/74/EK TrJC: EmTponfic;........ 2 Ap. <l>uAAou 618 18 Mafou 2006 E<l>HMEPII THI KYBEPNHIEnI (TEYXOI aEYTEPO) 8189 Ap18. 117800 (2) AvwTOTO 'OpLa YTTOA£Lpf1CITWV (MRLs) TWV cpurncpappOKWV ethofumesate, lambda-cyhalothrin, methomyl, pyme­ trozine KOL thiabendazole, rn( KOL £VT6c; Tpocp(µwv cpu­ TLK17c; npoi::Aworic; a£ evapµ6v1011 npoc; TT'JV 0011y10 2005/74/EK TT'J<; EmTpon17c;. 01 vnovPro1 OIKONOMIAI KAI OIKONOMIKnN ArPOTIKHI ANAnTY::HI KAI TPO<l>IMnN 'ExovTac; un6ljJ11: 1. To 6p8po 1 nap. 1, 2, 3 KOL 4 TOU V. 1338/1983 «Ecpapµoy17 Tou KotvonKou L'ltKa(ou» (A'34) 6nwc; Tpo­ nono117011Ke an6 TO 6p0po 6 TOU V. 1440/1984 (A70) KOi TO a.p8po 65 TOU V. 1892/90 (A'101). 2. To 6p8po 14, nepIm. I½ Tou v. 721/1977, 6nwc; Tpo­ nono117811Ke µe TO 6p8po 8 napa.ypacpoc; 2 Tou v. 2732/ 30.7.1999 (A'154). 3. To 6p8po 90 Tou «Kwo1Ka Noµo8w(ac; yI0 TT'JV Ku­ ~tpv11011 KOL TO Ku~epvrJTLKO bpyava» 6nwc; KWOLKono117 811Ke µe To n.o. 63/2005 (A' 98) KOL Tou yeyov6TOc; 6n an6 nc; 01m6.E;e1c; TT'JC: napouaac; an6cpaaric; oev npoKall.e(TOL oan6v11 ae ~6.poc; TOU KpOTIKOU npoOnoAoy1aµou. Oµaocc; KUl rrapaotiyµaTa µi:µovroµtvwv rrpoi6v--rwv lambda ym Ta orro(a t<YXi>ouv Ta Pymetrozine avro-i-a'Ta i:n(ncoa cyhalothrin \l1tOA£tµµaTlllV 1. Kap,ro(, vco,roi, ano;11paµtvo\ fJ li'l"ITOI., <JllVTl)poi>µ&VOl µi: ljlll;TJ, xwp(i; npoa0fJKlJ ~axap11i;· aKp6l>pua (i) EI.IlEPIAOELrn 0.3(p) fKp&Ut-(ppO\lT 0.1 Ai:µ6vta 0,2 Atµcniei; 0.2 Mavrapivm (cruµm:pv..aµ~avovTat 01 0.2 KA.l)µi::vtivE<; Kut aUa u~p{llta) 4. Triv un' ap18µ. 290341/20.7.1988 (8' 560) Ko1v17 unoup­ y1K17 an6cpaa11 nou acpop6 aTov Ka8op10µ6 avwTa.Twv op(wv UTTOA.£Lµµa.TWV yewpyLKWV cpapµa.KWV OTO Ol­ Tr]PO nou TTPOOPL½OVTOL y10 av8pwmv11 OlOTpocp17, 0£ auµµ6pcpwori npoc; TT'JC: 0011y10 86/362/EOK. 5. Triv un' ap18µ. 352654/10.5.1995 (8'518) Ko1v17 unoup­ y1K17 an6cpaa11, nou acpop6 oTov Ka8op10µ6 avwTa.Twv op(wv UTTOA.£lflf10TWV CDUTOTTPOOTOT£UTIKWV npoY6VTWV rn( KOL i::vT6c; op1oµivwv npo'iovTwv cpuT1K17c; npm:Aw­ aric; auµnep1Aaµ~avoµivwv TWV onwpOKT'JTTWTLKWV, ae auµµ6pcpwori npoc; TT'JV ooriy(a 90/642/EOK. 6. Triv un' apt0p. 2005/74/EK ooriy(a TTJC: EmTponfic; TTJC: 2511c; OKTW~p(ou 2005 (L282/26.10.2005) yI0 TT'JV Tpono­ no(11011 TT'JC: Ooriy(ac; 90/642/EOK Tou Iuµ~ouAfou ae 6,n acpop6 TO AvwTOTO 'Op10 Yn0Ae1µµ6Twv y10 op1aµiva cpurncp6pµ6Ka nou op(~ovTOL OTT'JV i::v ll.6yw 0011y10. 7. Triv un' ap18µ. Y132/11.10.2004 (<!>EK 1533/8/14.10.2004) KOIVl7 OTTO<pOOrJ TOU npw8unoupyou KOL TOU Ynoupyou AypoT1K17c; Av6mu~ric; KOL Tpocp(µwv y10 "ava.8£011 apµoo10T17Twv aTov Ycpunoupy6 AyponK17c; Av6mu~ric; KOL T pocp(µwv AM;avopo KovT6", anocpao(½ouµ£: Ap8po 1 (6p0po 1 TTJC: ooriy(ac; 2005/74/EK) LTO napa.pTT'JflO I TT'JC: KOIVl7<:; unoupy1K17c; an6cpaa11c; 352654/10.05.95 (8'518): a) OTT'JV Kmriyop(a 1, (vi) L'l16cpopa <l>pOUTO, µna~u TWV npo'(OVTWV «E:A.Ll::c;» KOL «Kapno( TT]C: namcpAwpac;» npOOTL0nOL TO npo'i6v «Kapno( nan61ac;», ~) OTT'JV Km11yop1a 2, (i) P1½wµmwo11 KOL KovouAwo17 /\axav1 K6, µna;u T(l)V npo'iOVTWV «KapOTO» KOL «PanavooiALVQ» npooT(0nm TO npo'i6v «Pf~ec; µav16Ka<; (cassava)». Ap8po 2 (6p8po 2 TT'JC: ooriyfac; 2005/37/EK, nAPAPTHMA Ill KOL nAPAPTHMA IV) a) Ta aK6Aou0a AvwTaTa 'Op10 YnoA.£1µµ6.Twv TWV cpuTocpapµa.Kwv ethofumesate, lambda-cyhalothrin, methomyl, pymetrozine KOL thiabendazole avnK0810Touv OUTO nou avacptpovTOL OTO nap6pTrJJ10 II TT'JC: Ko1v17c; unoupy1K17c; an6cpao11c; 352654/10.0595 (8'518): Ethofumesate (u0pot<Jµa ethofumesate Km Methomyl/ metabolite 2,3 Thiodicarb dihydro-3,3 (a0pot<Jµa dlmethyl-2-oxo- Thiabendazole benzofuran-5-yJ 1tO\l methane EK<ppO:~ETUl sulphonate iroll mi; methomyl) EK<ppa~ETUl we; ethofumesate) 0,05*(p) 5 0,5 1 1 I 8190 E<l>HMEPII THI KYBEPNHIEnI (TEYXOI tiEYTEPO) llopi-oK<iAtct 0.1 0,5 <I>pam:~ 0.1 0,5 Allct 0.02* 0.05* (ii) AKPOAPY A (µ1c: 1j 0.02'"(p) o.o5• o.os• 0.1 • xwpi<; KEAu<po<;) AµuyoctAct Kapulitu Bpul;tAim; A vaK6.potu (K6.01ou.;) K6.muvu Kupuor.c; cI>ouVTOUKtu MaKuv16.µw. Kapuom 7tEKUV KovKovvaptct <l>t<HlKUl KotV<i Kapuota AAAU (iii) MHAOEIAH 0.02*(p) 0.1 0,2 MiJAct 5 AxAMtu 5 Kvocbvta AUu 0.05* (iv) TTYPHNOKAPITA 0.05* Bi:piKOKU 0.05(p) 0.2 0,2 Ki:p6.cna 0,1 Po&u,nvu ( cmµncptAU/l~C!VOVlat 0.05(p) 0.2 0,2 vi:Kmpivtu Kut nap6µota ufJp(otu) AuµaaKTJVCX 0,5 AUu 0.02*(p) 0.1 0.05* (v) MOYPA KA1 MIKPOI 0.02*(p) 0.05"' KAPllOI (a) fampum':l:;ta Km 0.2 01vonou1cnµu. 01:u.cpu'.l..w. En:11:panti;iu omq>uAm 0.05"' OtvonmiJcnµa crmq>uAtu. l (~) <I>pciouAtc; ( EKT6c; un6 Ttc; 0.5 0.05* uypmq>paou'.l..i:c;) (y) Ku.pnoi ~ai-ov (i:n6.; 0.02* 0.05* an:6 wui; ayptoui;) Bm6µovpu Kupn:oi acmpo~uwµovptcii; Kapn:oi rou ytvouc; Rubus loganobaccus (Loganberries) .Eµtoupa .. ,. Alla (6) ;6.llo1 µucpo{ 1eap1toi Kcrt µoupa ( f:KT6<; un6 wuc; 0.05* 6.yp1ouc:) Mupn'.1..'.1..a (Kapnoi wu ytvouc: Vaccinium mvrtillus MupTtAA.U µmcp6Kap1tct ... <!>pctyKOOT!l(j)UA.Cl ( K6KKtVU, 0.1 acmpa iJ µaupa) TipetatV<l <pp<l')'KO<Het<pl)A.<l 0.1 'AAA.Cl 0.02* (i:) Aypw. µoupa Kat ayplO\ 0.2 0.05* KUpJtO{ (vi) MA«I>OPA «I>POYTA 0.02*(p) 0.02+ o.os• <!>EK 618 E<l>HMEPII THI KYBEPNHIEnI (TEYXOI aEYTEPO) 8191 A(3oKetvtO 15 Mrravavsc; 5 Xoupµa6Ei; Ll)Kll AKnviota KouµKou6:r Aircn MavyKo 5 Elite; Kaprroi rrarratai; 10 Kaprroi n1c; 1taaupA.6pac; Avavai; TTamiyta AAAU 0.05* 2. Aa:x:av1Ku, vwnu 11 U~pOO'TO, KOTEljllJ'yµtva 1] a,roc,qpaµf.va (i) PIZfiMA T!M,H KAI KONAYA!!AH 0.02*(p) AAXANIKA TTcnt;apta 0.1 (p) Kap6ta Pil;i;c; µuv16Ko.~ (cassava) 15 P(lJIUVOCT:':AtVO 0.1 Xptva Kov6u101 11116.veou TTaanvaKll Pit;E<; µu'tv-mvou Parravta 0.1 0,5 Aay6xoprn f1.UK07!CI.TUTC~ 15 foUAIII ( Eioo.:; KpaµP11c;) foyyu11.m K6vliu1..01 n1c; litoaKopt«<; 15 A).,).,a 0.02+ 0,05*(p) 0.05* 0.05* (ii) BOABHAH o.02•(p) 0,05*(p) 0.05* 0.05* AAXANIKA LK6pl>u KpEflflUOta A aKUAOlVIU ( EOUAOT) <DpfoKU KpEµµUOUKIU 0.05 AA.AU 0.02* (iii) KAPIIO«l>OPA 0,05*(p) 0.05* AAXANIKA (a) folawoo11 Toµan:c; 0.S{p) 0.1 0,5 TTt1tEptti; l{p) 0.1 0.2 ME1rrt;avsc; 0.S(p) 0.5 0,5 AUu 0.02*(p) 0.02+ o.os• (P) Ko1oKUv0oe:tol'J µe: 0.S(p) 0.1 0.05* ppwcnµo (j)AOIO Ayyoupm AyyoupaKm KOAOKU0ctKIU AMU (y) KoAoK1Jv0ocu511 µc µf\ 0.2(p) 0.05 o.os+ pproatµo (j)A.Ot6 8192 E<l>HMEPII THI KYBEPNHIEnI (TEYXOI tiEYTEPO) Tien6vm Ko1..0K1J8cc; Kupnovt;m AXAa (o) D.uKo KllAaµnoK1 o.02•(p) 0.05 0.05* (iv) KPAMBE!: 0,05*(p) (a) Av0oKpliµf3cs 0.02*(p) 0.1 Mnp6KoAu 0,2 5 Kouvouniom ,U1a 0.05"' 0.05* (f\) KEq>UAuHES Kpaµf\i:c; 0.05* 0.05* Aaxava Bpu~cUrov 0.05 J\uxuvu (Ki:q>aAw1u) 0.05 (p) 0.2 AAAU 0.02*(p) 0.02* ( y) <l>uMW&i:w; Kpaµflec; I 0.05* 0.05* K1vtt;um 16.xava Aaxaviocc; 0.1 (o) A.AAU o.02•(p) (o) royyu11.0Kpaµfli:c; 0.02*(p) 0.02* 0.05* 0.05* (v) Cl>Y AAQAH AAXANIKA KAI 0.05* AP!lMATlKA <l>YTA (u) MapouAta Km 1rap6µoia l(p) 1 0,05*(p) Kapoaµo AuK01p(l3011.o Mapou11.1 2 EKap61a (mKpioa) AMU 0.05* (13) EnavuKta Km 11ap6µom 0.02*(p) 0.5 0,05*(p) 2 :ErruvCtKta LfoKOU/1.U AA.AU (y) NcpoKCtpoaµo 0.02*(p) 0.02+ 0,05'"(p) 0.05* (Ii) PaliiKt Witloof 0.02*(p) 0.02* 0,05*(p) 0.05* (i;) ApwµanKa (J)t>Ta l(p) 1 " 1 (p} 2 LKUVTt;{KI ( <I>payKoµai:vmv6c;) Lxmv6npacm Ma1vmv6c; <l>uUa OEAIVOU AUa (vi) 'l'YXAN0H (vrona) 0.02*(p) 0,05*(p) 0.05* 0.05* <1Jau611.ta ([IE TO AOl36) 0.2 <1>ao611,1a (xcopis t..of36) 0.02* Mml/11.m (pc TO Aof\6) 0.2 Mm1;t11a (xropfc; 1..0~6) 0.2 AUa 0.02* (vii) !:TEAEXOAH 0.02*(p) 0,05*(p) 0.05* 0.05* AAXANlKA (vwna) Enapayyta A.yp1Si; a-y1<wapci; Eu,iva 0.3 Mupa0o E<l>HMEPII THI KYBEPNHIEnI (TEYXOI aEYTEPO) Ay1ov<'.lp&<; llp<'.lcra 0.3 Pct~tvn AD.a 0.02+ (viii) ElAH 0.02*(p) 0,05*(p) 0.05* MANITAPIQ.N ( u) Ku111,11:;pyouµ1:.'VU 0.02* r1avrr<'.lptu (~) Aypta µuvtr<'.lpta 0.5 J.m:nPJA 0.02"'(p) 0.02* 0,05*(p) 0.05* <t>acr6hu «l>UKE<; MmC,t11,1u AD.a 4. EAAIOYXOT l:TIOPOI 0.02* 0,1 *(p) Atvap6crnopo,; Apuxiocc; (ap<XltlKU 0,1 (l)UCTTIKlU) L1t6po1nunupouvui:; :En6pot croucraµtou :En6pot TJAl<'.lv0ou faopol EA.atOKp«µrT]<; I:6ytu 0,1 I:tvfutt Baµ~uK6crnopo,;; 0.05(p) 0, 1 'AJJ .. a 0.02*(p) 0.05* 5. IlATATEI: 0.02*(p) 0.02* 0,05"(p) 0.05" TTa-t<X't&<; ( <ppfoK&<;) TTm<XtE<; ( UJt00i]Kc\lµS:VE<;) 6. TI:AI (curol;ripaµtva (j>lJMU KUl 0-TEA.E'.m Tll 07t0lll E'f.OUV l)ffOOTEl 0.1 *(p) 1 0,1 *(p) 0.1 * t;i>µwori it O)'.l Tou Camellia .~inensis) 7.AYKU:KOI: ( a11:ol;11piiµtvoi:;), ouµ1r&ptMIµJlavoµtvrov S(p) 10 0, I *(p) 10 TffiV OluKimv >..\)K(uKou Km rric; µ11 ouµmJKVOlµEV1Jc; 0-KOVt]c; (*) AvmpepErnt crw Km6nepo 6pto uvu1unKoi> npocrotoptcrµou (p) 11nooT]1..cilvEt i:o npocrmp1v6 avcilm10 6pt0 u1to1..Etµµ(m11v <J1Jµq>rova µE 10 upOpo 4 nap<Xypuq>o~ l m0txsio cr1) tT]<; o&T]yiuc; 91/414/EOK 10 0.05* 0.05* 0.05 .. 0.05* 15 0.1 * 0.1* ~) Ta aK611.ou0u Avcinum 'Opm Ynok;iµµa:ww wu cpmmpupµ6.Kou ethofumesate 1tpo«rri8&VTat O"to llapaptTJ~m JI TTJ<; Koiv~<; Ynoupyttj<; A1t6cpacn1<; 352654/10.0595 (B'518): Oµaliei:; Kill 1111pu6Ei'yµaTa µ&µovroµtvcov ,rpoloVTcov y1a Ta ono{u \ff'f.'llOUV TU µtyurra Op\Q U7!0A.&1µµaTWV 8. KapuK&'llµUTU Ethofumesate (a6polffµa ethofumesate Kai metabolite 2,3 dihydro-3,3-dimethyl-2-oxo­ benzofuran-S-yl methane sulphonate nou EKq>pa~&Ta1 roi:; ethofumesate) ~ 8193 8194 E<l>HMEPII THI KYBEPNHIEnI (TEYXOI tiEYTEPO) '!:n:6pot Kuµivou Kapnoi KEOpou MoazoKupuoo Mmipo Km aan:po mn:fpt Kapn:oi pavO.im; .U.l.11 • J\ vacpl:pETm crro Karcori:po 6pw ava)..unKou 1tpoaowp1aµou (p) Y 1too11)..0vi:1 wv Ka0optaµ6 1tpoawp1vwv µi:y10w1v opirnv u110)..nµ~11hrnv auµqxovu µi; TO cip0po 4 rrapciypmpoc; I, crr0txdo en) TI]c; ooTjyiac; 91/414/EOK. Ap8po 3 (6p8po 3 Tnc: oonvfoc: 2005/74/EK) 01 OIOT0~£1C: TnC: nopouooc: on6cpoonc: ecpopµ61'.;ovTOL on6 TT]V 27n Anp1Afou 2006 H on6cpoon OUT~ VO onµomw8d OTT]V Ecpnµep[oo TT]C: Ku~epvfpewc;. A8~vo, 26 Anp1Afou 2006 01 YnOYP,01 OIKONOMIAI KAI OIKONOMIKQN r. AJ\OrO:rKOY<l>H:r Y<t>Yn. A,POTIKHI ANAnTY:':HI KAI TPO<l>IMQN A. KONTO:r

Ministerial Joint Decree No. 117800 as regards maximum residue levels for ethofumesate, lambda−cyhalothrin, methomyl, pymetrozine and thiabendazole in and on certain products of plant origin, in compliance with Commission Directive 2005/74/EC · Nelum